Clinical Trial Update: To Examine The Effects Of Lapatinib On Orally And Intravenously Administered Midazolam In Cancer Patients [Phase 1]

View source ↗

Summary

A Phase 1 clinical trial update examining how lapatinib affects midazolam when given by mouth or intravenously in cancer patients; the study status is completed…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Breast Cancer

Drugs mentioned

• Lapatinib (Tykerb) (lapatinib)
• Midazolam (Midazolam)

Snippet

Sponsor: GlaxoSmithKline | Conditions: Neoplasms, Breast | Phase 1 | Status: COMPLETED